Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.

Abstract

BACKGROUND:

While multiagent chemotherapy has dramatically improved the prognosis of sarcoma, the novel chemotherapeutics have hardly developed over the past 30 years. Caffeine can induce apoptosis, delays in cell cycle progression and can enhance the cytocidal effects of anti-cancer agents. Citrate has been reported to enhance the cytocidal effect of cisplatin in gastric cancer in vitro. However its effect in sarcoma cells had not been reported.

METHODS:

This study was designed to evaluate whether the addition of caffeine, citrate, or caffeine citrate to cisplatin improved its cytocidal effect (cell survival, proliferation, and apoptosis) on human osteosarcoma (HOS), human fibrosarcoma (HT1080) and murine osteosarcoma (LM8) cell lines. We also tested the various combinations in a mouse heterotopic transplantation model in vivo. In cell survival assay, combination index (CI) of caffeine citrate was calculated as a combination of anhydrous caffeine and citric acid, and the synergy was evaluated (CI < 1.0).

RESULTS:

In all cell lines, cisplatin combined with caffeine citrate significantly reinforced the anticancer effect compared with cisplatin alone, combination of cisplatin and anhydrous caffeine, and combination of cisplatin and citric acid. Moreover, CI was < 1.0 in all conditions. The anticancer agent reinforcement effect of caffeine citrate was synergy of anhydrous caffeine and citric acid. In cell proliferation and cell cycle assay revealed that caffeine citrate had most strong effect as a combination drug than caffeine and citric acid in inducing G0/G1 cell-cycle arrest with subsequent suppressed cell proliferation. In mitochondrial depolarization and caspase 3/7 activity assay revealed that caffeine citrate had most strong effect as a combination drug than caffeine and citric acid in apoptosis associated with decreased mitochondrial membrane potential. In vivo, three different drug concentrations were tested, and cisplatin combined with caffeine citrate was found to have the strongest antitumor effect.

CONCLUSIONS:

This is the first report demonstrating that caffeine citrate has a significantly greater potentiating effect on cisplatin than adding either caffeine or citric acid. The combination of cisplatin with caffeine citrate is a novel treatment that might hold promise for improving the outcome of osteosarcoma and fibrosarcoma, which up till now has generally not responded well to chemotherapy.

• Authors: Kensaku Abe, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Hiroyuki Tsuchiya
• Journal: BMC cancer (BMC Cancer) Vol. 19 Issue 1 Pg. 689 (Jul 15 2019) ISSN: 1471-2407 [Electronic] England
• PMID: 31307409 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Central Nervous System Stimulants
• Citrates
• Caffeine
• Cisplatin
• caffeine citrate

Topics

• Animals
• Antineoplastic Agents (administration & dosage, therapeutic use)
• Apoptosis (drug effects)
• Bone Neoplasms (drug therapy)
• Caffeine (administration & dosage, therapeutic use)
• Cell Cycle Checkpoints (drug effects)
• Cell Line, Tumor
• Cell Proliferation (drug effects)
• Cell Survival (drug effects)
• Central Nervous System Stimulants (administration & dosage, therapeutic use)
• Cisplatin (administration & dosage, therapeutic use)
• Citrates (administration & dosage, therapeutic use)
• Drug Synergism
• Drug Therapy, Combination
• Female
• Fibrosarcoma (drug therapy)
• Humans
• Membrane Potential, Mitochondrial (drug effects)
• Mice
• Mice, Nude
• Osteosarcoma (drug therapy)
• Treatment Outcome
• Tumor Burden
• Xenograft Model Antitumor Assays